VERA Vera Therapeutics Inc
Price (delayed)
$27.7
Market cap
$1.77B
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.75
Enterprise value
$1.73B
Highlights
VERA's equity has soared by 100% since the previous quarter
The quick ratio has soared by 89% from the previous quarter
The net income has plunged by 59% YoY and by 13% from the previous quarter
VERA's EPS is down by 22% year-on-year and by 5% since the previous quarter
Key stats
What are the main financial stats of VERA
Market
Valuations
Earnings
Shares outstanding
63.75M
Market cap
$1.77B
Enterprise value
$1.73B
Price to earnings (P/E)
N/A
Price to book (P/B)
3.04
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$167.17M
Net income
-$152.15M
EBIT
-$144.52M
EBITDA
-$142.35M
Free cash flow
-$135.65M
Per share
Balance sheet
Liquidity
EPS
-$2.75
EPS diluted
-$2.75
Free cash flow per share
-$2.45
Book value per share
$9.11
Revenue per share
$0
TBVPS
$11.85
Total assets
$655.68M
Total liabilities
$78.53M
Debt
$54.64M
Equity
$577.16M
Working capital
$625.85M
Debt to equity
0.09
Current ratio
25.67
Quick ratio
25.26
Net debt/EBITDA
0.27
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-33.1%
Return on equity
-39.3%
Return on invested capital
-32.9%
Return on capital employed
-22.9%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VERA stock price
How has the Vera Therapeutics stock price performed over time
Intraday
1.32%
1 week
-1.7%
1 month
-6.17%
1 year
-36.2%
YTD
-34.5%
QTD
-34.5%
Financial performance
How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$167.17M
Net income
-$152.15M
Gross margin
N/A
Net margin
N/A
VERA's operating income has dropped by 64% year-on-year and by 15% since the previous quarter
The net income has plunged by 59% YoY and by 13% from the previous quarter
Growth
What is Vera Therapeutics's growth rate over time
Valuation
What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
3.04
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS is down by 22% year-on-year and by 5% since the previous quarter
VERA's equity has soared by 100% since the previous quarter
VERA's P/B is 53% less than its last 4 quarters average of 6.4
Efficiency
How efficient is Vera Therapeutics business performance
The ROIC has soared by 50% YoY and by 15% from the previous quarter
VERA's return on equity is up by 46% year-on-year and by 22% since the previous quarter
The ROA has increased by 35% year-on-year and by 16% since the previous quarter
Dividends
What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VERA.
Financial health
How did Vera Therapeutics financials performed over time
The quick ratio has soared by 89% from the previous quarter
The company's current ratio has surged by 87% QoQ
VERA's debt is 91% smaller than its equity
VERA's equity has soared by 100% since the previous quarter
Vera Therapeutics's debt to equity has shrunk by 83% YoY and by 53% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.